Related Experiment Video
Updated: May 21, 2025
10:29
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
7.7K
Recent advancements in tuberculosis (TB) treatment regimens
Shyamala Ravikoti1, Vikas Bhatia2, Saykkulandai Kuppuswamy Mohanasundari3
1Department of Microbiology, AIIMS Bibinagar, Telangana, India.
Journal of Family Medicine and Primary Care
|March 21, 2025
Summary
Tuberculosis (TB) incidence is rising, especially drug-resistant forms. New treatments like the BPaLM regimen and advanced diagnostics offer hope for improved global TB control.
Area of Science:
- Public Health
- Infectious Diseases
- Medical Research
Background:
- Tuberculosis (TB) presents a significant global health burden, with increasing incidence and mortality.
- Drug-resistant TB, including multidrug-resistant (MDR) and rifampicin-resistant (RR) strains, poses a major treatment challenge.
- Limited diagnosis and treatment rates for drug-resistant TB highlight the urgent need for innovative solutions.
Purpose of the Study:
- To review recent advancements in tuberculosis treatment regimens.
- To highlight innovations in TB diagnostics for improved detection.
- To discuss progress in TB vaccine development and its potential impact.
Main Methods:
- Review of current literature on TB treatment, diagnostics, and vaccines.
- Analysis of data on TB incidence, mortality, and drug resistance.
- Evaluation of the efficacy of novel therapeutic regimens and diagnostic tools.
Main Results:
- The 6-month BPaLM regimen shows an 89% success rate for multidrug-resistant/rifampicin-resistant TB.
- Advanced diagnostics, including molecular tests and AI-assisted radiography, improve detection accuracy.
- Significant progress in vaccine development with 16 candidates in clinical trials.
Conclusions:
- Recent innovations in treatment, diagnostics, and vaccines are crucial for combating drug-resistant TB.
- The BPaLM regimen and new diagnostic tools offer improved outcomes for MDR/RR-TB.
- Continued research and implementation of these advancements are vital for global TB control efforts.
Related Concept Videos
01:28Pulmonary Tuberculosis V
159
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
159
01:26Pulmonary Tuberculosis IV
127
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
127
01:29Pulmonary Tuberculosis I
214
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
214
01:28Pulmonary Tuberculosis II
202
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
202
01:31Pulmonary Tuberculosis III
283
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
283
01:28Pneumonia IV: Management
282
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
282